North America Electronic Clinical Outcome Assessment (eCOA) Market Overview
According to SPER Market Research, the North America Electronic Clinical Outcome Assessment (eCOA) Market is estimated to reach USD 942.94 billion by 2032 with a CAGR of 17.13%.
Clinical trial outcomes data are electronically collected using the Electronic Clinical Outcome Assessment (eCOA) approach. eCOA enables trial participants, doctors, and caregivers to directly report data regarding healthcare outcomes using technology like mobile phones, tablets, and the internet. An increase in clinical trials is urgently required to boost compliance, efficiently acquire, and manage clinical data. Market expansion is predicted to be fuelled by the desire to save expenses and a rise in R&D activity. New methods for developing medications are gradually moving away from paper-based processes in favour of electronic data acquisition to lower overall costs. When data are collected using electronic clinical outcome assessment platforms, the quality of the data is increased, data collection procedures are standardized, and data analysis is provided to users at a significant benefit. All of the problems of paper-based records are eliminated by electronic data collecting and analysis systems, which also increase patient compliance.
Additionally, they eliminate the possibility of data fluctuation and reduce the expense of site monitoring. In the upcoming years, product demand is anticipated to be driven by the benefits of adopting electronic clinical outcome assessments that were just described. Thus, it is becoming more common to evaluate the effectiveness of various chronic illness medications using clinical outcome evaluations (COAs). The regulatory approval of medications has frequently depended on these. Its expansion will also be aided by the installation of a variety of services.
Impact of COVID-19 on the North America Electronic Clinical Outcome Assessment (eCOA) Market
The COVID-19 pandemic made it difficult to manage the clinical study. In order to solve these issues and ensure the continuation of clinical research activities, market participants undertook a number of measures, including the use of eClinical technology. Due to the outbreak, clinical studies were converted to digital format. A rising number of sponsors, biopharma companies, medical device companies, and contract research organizations (CROs) have started using eClinical platforms to acquire, organize, and extract meaningful insights from data in a remote, economical manner. Remote access to patient data is possible with the use of electronic clinical outcome evaluation (eCOA).
-00832427022023.jpg)
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Product, By Approach, By Platform, By Delivery Mode, By End User
|
| Regions covered | Canada, Mexico, U.S.
|
| Companies Covered | Clario, Climedo Health GmbH, ClinCapture, Cloudbyz, CRF Health, eClinical Solutions, IBM Corporation, IQVIA, Medidata Solutions, Inc., OmniComm Systems, Inc., Oracle Corporation, Paraxel International Corporation, Signant Health, TransPerfect
|
North America Electronic Clinical Outcome Assessment (eCOA) Market Segmentation:
1. By Product:
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
2. By Approach
- Clinician- reported Outcome
- Observer- reported Outcome
- Patient-reported Outcome
- Performance Outcome
3. By Platform
- Consulting Service Companies
- Contract Research Organizations
- Hospitals and Clinical Laboratories
- Medical Device Manufacturers
- Pharmaceutical and Biopharmaceutical Companies
- Research and Academia
- Others
4. By Delivery Mode:
5. By End User:
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Laboratories and Academia Institutions
6. By Region:
Key Topics Covered in the Report:
- Size of North America Electronic Clinical Outcome Assessment (eCOA) Market (FY’2019-FY’2032)
- Overview of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Product (Cloud Based Solutions, On-Premise Solutions, Web Based Solutions)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Approach (Clinician- reported Outcome, Observer- reported Outcome, Patient-reported Outcome, Performance Outcome)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Platform (Consulting Service Companies, Contract Research Organizations, Hospitals and Clinical Laboratories, Medical Device Manufacturers, Pharmaceutical and Biopharmaceutical Companies, Research and Academia, Others)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Delivery Mode (Cloud-hosted, Web-hosted)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By End User (Commercial Service Provider, Hospitals and Transplant Centers, Research Laboratories and Academia Institutions)
- Statistical Snap of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Growth Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Problems and Challenges in North America Electronic Clinical Outcome Assessment (eCOA) Market
- Competitive Landscape in the North America Electronic Clinical Outcome Assessment (eCOA) Market
- Impact of COVID-19 and Demonetization on North America Electronic Clinical Outcome Assessment (eCOA) Market
- Details on Recent Investment in North America Electronic Clinical Outcome Assessment (eCOA) Market
- Competitive Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Major Players in the North America Electronic Clinical Outcome Assessment (eCOA) Market
- SWOT Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- North America Electronic Clinical Outcome Assessment (eCOA) Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the North America Electronic Clinical Outcome Assessment (eCOA) Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 North America Electronic Clinical Outcome Assessment (eCOA) Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in North America Electronic Clinical Outcome Assessment (eCOA) Market
7. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Product, 2019-2032 (USD Million)
7.1 Cloud Based Solutions
7.2 On-Premise Solutions
7.3 Web Based Solutions
8. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Approach, 2019-2032 (USD Million)
8.1 Clinician- reported Outcome
8.2 Observer- reported Outcome
8.3 Patient-reported Outcome
8.4 Performance Outcome
9. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Platform, 2019-2032 (USD Million)
9.1 Consulting Service Companies
9.2 Contract Research Organizations
9.3 Hospitals and Clinical Laboratories
9.4 Medical Device Manufacturers
9.5 Pharmaceutical and Biopharmaceutical Companies
9.6 Research and Academia
9.7 Others
10. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Delivery Mode, 2019-2032 (USD Million)
10.1 Cloud-hosted
10.2 Web-hosted
11. North America Electronic Clinical Outcome Assessment (eCOA) Market, By End User, 2019-2032 (USD Million)
11.1 Commercial Service Providers
11.2 Hospitals and Transplant Centers
11.3 Research Laboratories and Academia Institutions
12. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Region, 2019-2032 (USD Million)
12.1 North America Electronic Clinical Outcome Assessment (eCOA) Size and Market Share by Region (2019-2025)
12.2 North America Electronic Clinical Outcome Assessment (eCOA) Size and Market Share by Region (2026-2032)
12.3 Canada
12.4 Mexico
12.5 U.S.
13. Company Profiles
13.1 Clario
13.1.1 Company details
13.1.2 Financial outlook
13.1.3 Product summary
13.1.4 Recent developments
13.2 Climedo Health GmbH
13.2.1 Company details
13.2.2 Financial outlook
13.2.3 Product summary
13.2.4 Recent developments
13.3 ClinCapture
13.3.1 Company details
13.3.2 Financial outlook
13.3.3 Product summary
13.3.4 Recent developments
13.4 Cloudbyz
13.4.1 Company details
13.4.2 Financial outlook
13.4.3 Product summary
13.4.4 Recent developments
13.5 CRF Health
13.5.1 Company details
13.5.2 Financial outlook
13.5.3 Product summary
13.5.4 Recent developments
13.6 eClinical Solutions
13.6.1 Company details
13.6.2 Financial outlook
13.6.3 Product summary
13.6.4 Recent developments
13.7 IBM Corporation
13.7.1 Company details
13.7.2 Financial outlook
13.7.3 Product summary
13.7.4 Recent developments
13.8 IQVIA
13.8.1 Company details
13.8.2 Financial outlook
13.8.3 Product summary
13.8.4 Recent developments
13.9 Medidata Solutions, Inc.
13.9.1 Company details
13.9.2 Financial outlook
13.9.3 Product summary
13.9.4 Recent developments
13.10 OmniComm Systems, Inc.
13.10.1 Company details
13.10.2 Financial outlook
13.10.3 Product summary
13.10.4 Recent developments
13.11 Oracle Corporation
13.11.1 Company details
13.11.2 Financial outlook
13.11.3 Product summary
13.11.4 Recent developments
13.12 Paraxel International Corporation
13.12.1 Company details
13.12.2 Financial outlook
13.12.3 Product summary
13.12.4 Recent developments
13.13 Signant Health
13.13.1 Company details
13.13.2 Financial outlook
13.13.3 Product summary
13.13.4 Recent developments
13.14 TransPerfect
13.14.1 Company details
13.14.2 Financial outlook
13.14.3 Product summary
13.14.4 Recent developments
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
